Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05557656
What this trial is testing

A Real World Study of Regogfinib in HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 800
Large-scale testing (Phase 3)WithdrawnNCT02527772
What this trial is testing

Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University
Early research (Phase 1)Ended earlyNCT05209295
What this trial is testing

Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Who this might be right for
Hepatic InsufficiencyNeoplasms
Bristol-Myers Squibb 2
Testing effectiveness (Phase 2)Study completedNCT00777894
What this trial is testing

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Swiss Cancer Institute 18
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT03963037
What this trial is testing

Characterization of Two Novel Mutations in the Apob Gene

Who this might be right for
Familial Hypobetalipoproteinaemia - Heterozygous FormLow-LDL-syndrome
Medical University Innsbruck 16
Not applicableStudy completedNCT00132041
What this trial is testing

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
American College of Radiology Imaging Network 51
Not applicableEnded earlyNCT04258566
What this trial is testing

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Who this might be right for
Hepatocellular Carcinoma
National Institutes of Health Clinical Center (CC) 7
Not applicableStudy completedNCT02670122
What this trial is testing

Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 131
Testing effectiveness (Phase 2)Looking for participantsNCT06280105
What this trial is testing

A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib

Who this might be right for
Hepatocellular Carcinoma
Meng Chao Hepatobiliary Hospital of Fujian Medical University 40
Not applicableActive Not RecruitingNCT05064553
What this trial is testing

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more
Exact Sciences Corporation 2,990
Early research (Phase 1)Study completedNCT03735628
What this trial is testing

Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Head and Neck Squamous Cell Carcinoma (HNSCC)Hepatocellular Carcinoma (HCC)
Bayer 16
Large-scale testing (Phase 3)Active Not RecruitingNCT05320692
What this trial is testing

TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 423
Testing effectiveness (Phase 2)UnknownNCT03971201
What this trial is testing

Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion

Who this might be right for
Hepatocellular Cancer
White Plains Hospital 200
Testing effectiveness (Phase 2)UnknownNCT00282100
What this trial is testing

Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Tan Tock Seng Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02509507
What this trial is testing

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCutaneous or Subcutaneous Lymph Node+1 more
Amgen 127
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableUnknownNCT04863144
What this trial is testing

Pharmacokinetics of Paclitaxel in Correlation With Adverse Events in Cancer Patients With and Without Liver Impairment

Who this might be right for
Liver Diseases
Ain Shams University 40
Not applicableEnded earlyNCT03516695
What this trial is testing

RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry

Who this might be right for
Liver Cancer
Boston Scientific Corporation 95
Testing effectiveness (Phase 2)Ended earlyNCT00938457
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Who this might be right for
Unspecified Adult Solid Tumor
Mayo Clinic 3
Next Page